InvestorsHub Logo
Followers 14
Posts 230
Boards Moderated 0
Alias Born 09/24/2021

Re: 1968cuda434 post# 129225

Monday, 10/04/2021 12:34:30 PM

Monday, October 04, 2021 12:34:30 PM

Post# of 198949
More short-shrifters today (sigh)

ENZC has 18 monoclonal patents and three immunotherapy patents. ITV-1 immunotherapy treatment has successfully tested in phase 3 trials with terrific results ( if the validation order had been properly produced the impact of that treatment would have already been realized).

Really hope that real investors can as see through the shorts. The “shorts” seem to be mad about last week’s presentation.